|
US139A
(en)
|
|
1837-03-11 |
|
Robert wilson |
|
US118A
(en)
|
|
1837-02-10 |
|
Improvement in the machine for weighing heavy bodies |
|
US119A
(en)
|
|
1837-02-10 |
|
Improvement in the machine for weighing heavy bodies |
|
US4186745A
(en)
|
1976-07-30 |
1980-02-05 |
Kauzlarich James J |
Porous catheters
|
|
US4235877A
(en)
|
1979-06-27 |
1980-11-25 |
Merck & Co., Inc. |
Liposome particle containing viral or bacterial antigenic subunit
|
|
US4372945A
(en)
|
1979-11-13 |
1983-02-08 |
Likhite Vilas V |
Antigen compounds
|
|
IL61904A
(en)
|
1981-01-13 |
1985-07-31 |
Yeda Res & Dev |
Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
|
|
US4436727A
(en)
|
1982-05-26 |
1984-03-13 |
Ribi Immunochem Research, Inc. |
Refined detoxified endotoxin product
|
|
US4866034A
(en)
|
1982-05-26 |
1989-09-12 |
Ribi Immunochem Research Inc. |
Refined detoxified endotoxin
|
|
SE8205892D0
(sv)
|
1982-10-18 |
1982-10-18 |
Bror Morein |
Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
|
|
EP0114787B1
(de)
|
1983-01-25 |
1991-09-25 |
Ciba-Geigy Ag |
Neue Peptidderivate
|
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US4707543A
(en)
|
1985-09-17 |
1987-11-17 |
The United States Of America As Represented By The Secretary Of The Army |
Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines
|
|
US4680338A
(en)
|
1985-10-17 |
1987-07-14 |
Immunomedics, Inc. |
Bifunctional linker
|
|
US5011828A
(en)
|
1985-11-15 |
1991-04-30 |
Michael Goodman |
Immunostimulating guanine derivatives, compositions and methods
|
|
US5149650A
(en)
|
1986-01-14 |
1992-09-22 |
University Of North Carolina At Chapel Hill |
Vaccines for human respiratory virus
|
|
US4877611A
(en)
|
1986-04-15 |
1989-10-31 |
Ribi Immunochem Research Inc. |
Vaccine containing tumor antigens and adjuvants
|
|
CA1331443C
(en)
|
1987-05-29 |
1994-08-16 |
Charlotte A. Kensil |
Saponin adjuvant
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US5726292A
(en)
|
1987-06-23 |
1998-03-10 |
Lowell; George H. |
Immuno-potentiating systems for preparation of immunogenic materials
|
|
US5639853A
(en)
|
1987-09-29 |
1997-06-17 |
Praxis Biologics, Inc. |
Respiratory syncytial virus vaccines
|
|
MX9203458A
(es)
|
1987-12-23 |
1992-09-01 |
Upjohn Co |
Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
|
|
US5278302A
(en)
|
1988-05-26 |
1994-01-11 |
University Patents, Inc. |
Polynucleotide phosphorodithioates
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
AU631377B2
(en)
|
1988-08-25 |
1992-11-26 |
Liposome Company, Inc., The |
Affinity associated vaccine
|
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
|
CA2017507C
(en)
|
1989-05-25 |
1996-11-12 |
Gary Van Nest |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
US4988815A
(en)
|
1989-10-26 |
1991-01-29 |
Riker Laboratories, Inc. |
3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
|
|
EP0452457B1
(en)
|
1989-11-03 |
1997-08-20 |
Vanderbilt University |
Method of in vivo delivery of functioning foreign genes
|
|
US5674192A
(en)
|
1990-12-28 |
1997-10-07 |
Boston Scientific Corporation |
Drug delivery
|
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
|
US5658731A
(en)
|
1990-04-09 |
1997-08-19 |
Europaisches Laboratorium Fur Molekularbiologie |
2'-O-alkylnucleotides as well as polymers which contain such nucleotides
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
DE69229114T2
(de)
|
1991-03-01 |
1999-11-04 |
Minnesota Mining And Mfg. Co., Saint Paul |
1,2-substituierte 1h-imidazo[4,5-c]chinolin-4-amine
|
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
US5936076A
(en)
|
1991-08-29 |
1999-08-10 |
Kirin Beer Kabushiki Kaisha |
αgalactosylceramide derivatives
|
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
US5266575A
(en)
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
|
MA22842A1
(fr)
|
1992-03-27 |
1993-10-01 |
Smithkline Beecham Biolog |
Procede de preparation de compositions de vaccin.
|
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
US5340740A
(en)
|
1992-05-15 |
1994-08-23 |
North Carolina State University |
Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process
|
|
US5587308A
(en)
|
1992-06-02 |
1996-12-24 |
The United States Of America As Represented By The Department Of Health & Human Services |
Modified adeno-associated virus vector capable of expression from a novel promoter
|
|
EP0646178A1
(en)
|
1992-06-04 |
1995-04-05 |
The Regents Of The University Of California |
expression cassette with regularoty regions functional in the mammmlian host
|
|
CA2138997C
(en)
|
1992-06-25 |
2003-06-03 |
Jean-Paul Prieels |
Vaccine composition containing adjuvants
|
|
CA2151597A1
(en)
|
1993-01-08 |
1994-07-21 |
Robert L. Garlick |
Process for the purification and refolding of human respiratory syncytial virus fg glycoprotein
|
|
US5395937A
(en)
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
|
US5776468A
(en)
|
1993-03-23 |
1998-07-07 |
Smithkline Beecham Biologicals (S.A.) |
Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A
|
|
JPH09500128A
(ja)
|
1993-07-15 |
1997-01-07 |
ミネソタ マイニング アンド マニュファクチャリング カンパニー |
イミダゾ〔４，５−ｃ〕ピリジン−４−アミン
|
|
US5352784A
(en)
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
|
US5961970A
(en)
|
1993-10-29 |
1999-10-05 |
Pharmos Corporation |
Submicron emulsions as vaccine adjuvants
|
|
WO1995011700A1
(en)
|
1993-10-29 |
1995-05-04 |
Pharmos Corp. |
Submicron emulsions as vaccine adjuvants
|
|
PL181241B1
(pl)
|
1993-11-17 |
2001-06-29 |
Deutsche Om Arzneimittel Gmbh |
Disacharydy beta(1 6)glukozoaminowe, sposób wytwarzania disacharydu beta(1 6) glukozoaminowego, zawierająca je kompozycja farmaceutyczna i środek immunomodulujący i/lub przeciwnowotworowy oraz szczepionka
|
|
US5397307A
(en)
|
1993-12-07 |
1995-03-14 |
Schneider (Usa) Inc. |
Drug delivery PTCA catheter and method for drug delivery
|
|
GB9326174D0
(en)
|
1993-12-22 |
1994-02-23 |
Biocine Sclavo |
Mucosal adjuvant
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
JP3403233B2
(ja)
|
1994-01-20 |
2003-05-06 |
テルモ株式会社 |
バルーンカテーテル
|
|
WO1995026204A1
(en)
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
FR2718452B1
(fr)
|
1994-04-06 |
1996-06-28 |
Pf Medicament |
Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
EP1167379A3
(en)
|
1994-07-15 |
2004-09-08 |
University Of Iowa Research Foundation |
Immunomodulatory oligonucleotides
|
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
|
FR2726003B1
(fr)
|
1994-10-21 |
2002-10-18 |
Agronomique Inst Nat Rech |
Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires
|
|
AU3876695A
(en)
|
1994-11-17 |
1996-06-17 |
Imperial College Of Science, Technology And Medicine |
Internalisation of dna, using conjugates of poly-l-lysine and an integrin receptor ligand
|
|
US6071890A
(en)
|
1994-12-09 |
2000-06-06 |
Genzyme Corporation |
Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
|
|
US5482936A
(en)
|
1995-01-12 |
1996-01-09 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-C]quinoline amines
|
|
GB9503863D0
(en)
|
1995-02-25 |
1995-04-19 |
Smithkline Beecham Biolog |
Vaccine compositions
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
US5811524A
(en)
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
|
US5666153A
(en)
|
1995-10-03 |
1997-09-09 |
Virtual Shopping, Inc. |
Retractable teleconferencing apparatus
|
|
US6020182A
(en)
*
|
1996-07-12 |
2000-02-01 |
Connaught Laboratories Limited |
Subunit respiratory syncytial virus vaccine preparation
|
|
US5856462A
(en)
|
1996-09-10 |
1999-01-05 |
Hybridon Incorporated |
Oligonucleotides having modified CpG dinucleosides
|
|
DK1005368T3
(da)
|
1997-03-10 |
2010-01-04 |
Ottawa Hospital Res Inst |
Anvendelse af nukleinsyrer, der indeholder ikke-metyleret CpG dinukleotid i kombination med alun som hjælpestoffer
|
|
US6818222B1
(en)
|
1997-03-21 |
2004-11-16 |
Chiron Corporation |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
|
|
US6764840B2
(en)
|
1997-05-08 |
2004-07-20 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US6113918A
(en)
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US6303347B1
(en)
|
1997-05-08 |
2001-10-16 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US6080725A
(en)
|
1997-05-20 |
2000-06-27 |
Galenica Pharmaceuticals, Inc. |
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
|
|
US6060308A
(en)
|
1997-09-04 |
2000-05-09 |
Connaught Laboratories Limited |
RNA respiratory syncytial virus vaccines
|
|
US6090619A
(en)
|
1997-09-08 |
2000-07-18 |
University Of Florida |
Materials and methods for intracellular delivery of biologically active molecules
|
|
BR9812240A
(pt)
|
1997-09-19 |
2000-07-18 |
American Cyanamid Co |
Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênica
|
|
US6129705A
(en)
|
1997-10-01 |
2000-10-10 |
Medtronic Ave, Inc. |
Drug delivery and gene therapy delivery system
|
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
|
GB9727262D0
(en)
|
1997-12-24 |
1998-02-25 |
Smithkline Beecham Biolog |
Vaccine
|
|
WO1999052549A1
(en)
|
1998-04-09 |
1999-10-21 |
Smithkline Beecham Biologicals S.A. |
Adjuvant compositions
|
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
|
AU7924598A
(en)
|
1998-06-08 |
1999-12-30 |
Sca Emballage France |
Fast flattening packaging
|
|
CN1168702C
(zh)
|
1998-06-30 |
2004-09-29 |
Om药业 |
酰基-二肽类化合物,其制备方法以及含有前述化合物的药物组合物
|
|
US6110929A
(en)
|
1998-07-28 |
2000-08-29 |
3M Innovative Properties Company |
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
|
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
|
KR100629028B1
(ko)
|
1998-10-16 |
2006-09-26 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
애쥬번트 시스템 및 백신
|
|
US20030130212A1
(en)
|
1999-01-14 |
2003-07-10 |
Rossignol Daniel P. |
Administration of an anti-endotoxin drug by intravenous infusion
|
|
US6551600B2
(en)
|
1999-02-01 |
2003-04-22 |
Eisai Co., Ltd. |
Immunological adjuvant compounds compositions and methods of use thereof
|
|
US20040006242A1
(en)
|
1999-02-01 |
2004-01-08 |
Hawkins Lynn D. |
Immunomodulatory compounds and method of use thereof
|
|
WO2000046147A2
(en)
|
1999-02-03 |
2000-08-10 |
Biosante Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles and methods of manufacture and use
|
|
ATE397942T1
(de)
|
1999-03-26 |
2008-07-15 |
Vical Inc |
Adjuvanszusammensetzungen zur erhöhung der immunantwort bezüglich polynukleotid-basierenden impfstoffen
|
|
US6331539B1
(en)
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
|
TR200200777T2
(tr)
|
1999-09-24 |
2002-09-23 |
Smithkline Beecham Biologicals S.A. |
Polioksietilen alkil eteri veya esteriyle en az bir iyonik olmayan yüzey aktif maddeli adjuvant.
|
|
HUP0202885A3
(en)
|
1999-09-24 |
2004-07-28 |
Smithkline Beecham Biolog |
Vaccines
|
|
NZ517929A
(en)
|
1999-09-25 |
2004-02-27 |
Univ Iowa Res Found |
Immunostimulatory nucleic acids
|
|
WO2001046127A1
(fr)
|
1999-12-22 |
2001-06-28 |
Om Pharma |
Pseudodipeptides acyles porteurs d'un bras auxiliaire fonctionnalise
|
|
US20010044416A1
(en)
|
2000-01-20 |
2001-11-22 |
Mccluskie Michael J. |
Immunostimulatory nucleic acids for inducing a Th2 immune response
|
|
ATE448226T1
(de)
|
2000-09-01 |
2009-11-15 |
Novartis Vaccines & Diagnostic |
Aza heterocyclische derivate und ihre therapeutische verwendung
|
|
DE60115069T2
(de)
|
2000-09-11 |
2006-08-03 |
Chiron Corp., Emeryville |
Chinolinonderivate als tyrosin-kinase inhibitoren
|
|
AU2001294750C1
(en)
|
2000-09-26 |
2008-09-18 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
|
|
WO2002042326A1
(en)
|
2000-11-22 |
2002-05-30 |
Biota Scientific Management Pty Ltd |
A method of expression and agents identified thereby
|
|
UA74852C2
(en)
|
2000-12-08 |
2006-02-15 |
3M Innovative Properties Co |
Urea-substituted imidazoquinoline ethers
|
|
US6677348B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Aryl ether substituted imidazoquinolines
|
|
US6677347B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
|
US6667312B2
(en)
|
2000-12-08 |
2003-12-23 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
|
US6664264B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
|
US6664265B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
|
DK1395669T3
(da)
|
2001-01-26 |
2009-11-16 |
Selexis Sa |
Matriks bindingsregioner og fremgangsmåder til anvendelse af disse
|
|
US7524509B2
(en)
|
2001-03-09 |
2009-04-28 |
Id Biomedical Corporation Of Quebec |
Proteosome-liposaccharide vaccine adjuvant
|
|
US7157465B2
(en)
|
2001-04-17 |
2007-01-02 |
Dainippon Simitomo Pharma Co., Ltd. |
Adenine derivatives
|
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
|
EP1455700A4
(en)
|
2001-11-16 |
2007-02-14 |
3M Innovative Properties Co |
METHODS AND COMPOSITIONS RELATED TO MRI COMPOUNDS AND TO TOLL-TYPE RECEPTOR (TLR) PATHWAYS
|
|
FR2832423B1
(fr)
|
2001-11-22 |
2004-10-08 |
Vivalis |
Systeme d'expression de proteines exogenes dans un systeme aviaire
|
|
US7321033B2
(en)
|
2001-11-27 |
2008-01-22 |
Anadys Pharmaceuticals, Inc. |
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
|
|
AP2004003069A0
(en)
|
2001-11-27 |
2004-06-30 |
Anadys Pharmaceuticals Inc |
3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof.
|
|
US6677349B1
(en)
|
2001-12-21 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
|
EP1485468A4
(en)
|
2002-02-21 |
2007-01-03 |
Medimmune Vaccines Inc |
RECOMBINANT PARAIN FLUENZAVIRUS EXPRESSION SYSTEMS AND VACCINES WITH ANTIGENS FROM METAPNEUMOVIRUS STEM-RELATED HETEROLOGISTS
|
|
FR2836924B1
(fr)
|
2002-03-08 |
2005-01-14 |
Vivalis |
Lignees de cellules aviaires utiles pour la production de substances d'interet
|
|
WO2003082272A1
(en)
|
2002-03-29 |
2003-10-09 |
Chiron Corporation |
Substituted benzazoles and use thereof as raf kinase inhibitors
|
|
AU2003227049A1
(en)
*
|
2002-04-03 |
2003-10-13 |
Akzo Nobel N.V. |
Viral mutants, manipulated in the furin cleavage sites of glycoproteins
|
|
WO2003101949A2
(en)
|
2002-05-29 |
2003-12-11 |
3M Innovative Properties Company |
Process for imidazo[4,5-c]pyridin-4-amines
|
|
AU2003251518B2
(en)
|
2002-06-13 |
2009-07-02 |
New York University |
Synthetic C-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
|
|
DE60333762D1
(de)
|
2002-08-23 |
2010-09-23 |
Novartis Vaccines & Diagnostic |
Pyrrolverbindungen als glykogen synthase kinase 3 inhibitoren
|
|
DK2311848T3
(da)
|
2002-12-23 |
2013-10-14 |
Vical Inc |
Kodon-optimerede polynukleotidbaserede vacciner mod human cytomegalovirus-infektion
|
|
US7521062B2
(en)
|
2002-12-27 |
2009-04-21 |
Novartis Vaccines & Diagnostics, Inc. |
Thiosemicarbazones as anti-virals and immunopotentiators
|
|
CA2513655C
(en)
|
2003-01-21 |
2011-11-22 |
Chiron Corporation |
Use of tryptanthrin compounds for immune potentiation
|
|
GB0301554D0
(en)
|
2003-01-23 |
2003-02-26 |
Molecularnature Ltd |
Immunostimulatory compositions
|
|
JP2006517974A
(ja)
|
2003-02-13 |
2006-08-03 |
スリーエム イノベイティブ プロパティズ カンパニー |
Ｉｒｍ化合物およびトル様受容体８に関する方法および組成物
|
|
WO2004087153A2
(en)
|
2003-03-28 |
2004-10-14 |
Chiron Corporation |
Use of organic compounds for immunopotentiation
|
|
US7368537B2
(en)
|
2003-07-15 |
2008-05-06 |
Id Biomedical Corporation Of Quebec |
Subunit vaccine against respiratory syncytial virus infection
|
|
RU2236257C1
(ru)
|
2003-09-15 |
2004-09-20 |
Косяков Константин Сергеевич |
Синтетический иммуноген для терапии и профилактики злоупотреблений наркотическими и психоактивными веществами
|
|
US7771726B2
(en)
|
2003-10-08 |
2010-08-10 |
New York University |
Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseases
|
|
KR101269656B1
(ko)
|
2003-10-24 |
2013-05-30 |
셀렉시스 에스. 에이. |
Ｍａｒ 서열의 복합 트랜스펙션 방법에 의한 포유동물 세포에서의 고효율 유전자 전달 및 발현
|
|
EP1528101A1
(en)
|
2003-11-03 |
2005-05-04 |
ProBioGen AG |
Immortalized avian cell lines for virus production
|
|
CA2560969A1
(en)
|
2004-03-31 |
2005-11-03 |
New York University |
Novel synthetic c-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases
|
|
KR20110132416A
(ko)
|
2004-04-05 |
2011-12-07 |
화이자 프로덕츠 인코포레이티드 |
미세유체화된 수중유 유화액 및 백신 조성물
|
|
JP5331340B2
(ja)
|
2004-05-18 |
2013-10-30 |
バイカル インコーポレイテッド |
インフルエンザウィルスワクチン組成物、及びその使用方法
|
|
WO2006002422A2
(en)
|
2004-06-24 |
2006-01-05 |
Novartis Vaccines And Diagnostics Inc. |
Compounds for immunopotentiation
|
|
FR2873378A1
(fr)
|
2004-07-23 |
2006-01-27 |
Pierre Fabre Medicament Sa |
Complexes immunogenes, leur procede de preparation et leur utilisation dans des compositions pharmaceutiques
|
|
CA2574375C
(en)
|
2004-07-23 |
2015-03-17 |
Chiron Srl |
Polypeptides for oligomeric assembly of antigens
|
|
GB0422439D0
(en)
|
2004-10-08 |
2004-11-10 |
European Molecular Biology Lab Embl |
Inhibitors of infection
|
|
CA2587084C
(en)
|
2004-10-08 |
2019-07-16 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Modulation of replicative fitness by using less frequently used synonym ous codons
|
|
US7951384B2
(en)
*
|
2005-08-05 |
2011-05-31 |
University Of Massachusetts |
Virus-like particles as vaccines for paramyxovirus
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
WO2008061243A2
(en)
*
|
2006-11-16 |
2008-05-22 |
Novavax, Inc. |
Respiratory syncytial virus-virus like particle (vlps)
|
|
WO2008114149A2
(en)
*
|
2007-03-21 |
2008-09-25 |
Id Biomedical Corporation Of Quebec |
Chimeric antigens
|
|
WO2008154456A2
(en)
*
|
2007-06-06 |
2008-12-18 |
Nationwide Children's Hospital, Inc. |
Methods and compositions relating to viral fusion proteins
|
|
CN101148479A
(zh)
*
|
2007-09-11 |
2008-03-26 |
浙江理工大学 |
一种重组类人胶原蛋白及生物合成方法
|
|
JP5711972B2
(ja)
|
2007-12-24 |
2015-05-07 |
アイディー バイオメディカル コーポレイション オブ ケベック |
組換えｒｓｖ抗原
|
|
CN102015651B
(zh)
|
2008-03-03 |
2014-12-31 |
Irm责任有限公司 |
作为tlr活性调节剂的化合物和组合物
|
|
AU2009236585B2
(en)
|
2008-04-18 |
2013-03-07 |
Vaxinnate Corporation |
Deletion mutants of flagellin and methods of use
|
|
WO2009132206A1
(en)
|
2008-04-25 |
2009-10-29 |
Liquidia Technologies, Inc. |
Compositions and methods for intracellular delivery and release of cargo
|
|
JP5781929B2
(ja)
*
|
2008-07-15 |
2015-09-24 |
ノバルティス アーゲー |
免疫原性の両親媒性ペプチド組成物
|
|
US20110177117A1
(en)
|
2008-07-18 |
2011-07-21 |
Normand Blais |
Chimeric respiratory syncytial virus polypeptide antigens
|
|
WO2010077712A1
(en)
|
2008-12-09 |
2010-07-08 |
Novavax, Inc. |
Bovine respiratory syncytial virus virus-like particle (vlps)
|
|
PL2370099T3
(pl)
*
|
2008-12-09 |
2016-10-31 |
|
Zmodyfikowane białka F RSV i sposoby ich zastosowania
|
|
HUE028085T2
(en)
|
2009-06-24 |
2016-11-28 |
Glaxosmithkline Biologicals Sa |
Recombinant RSV antigens
|
|
EP2445527A2
(en)
|
2009-06-24 |
2012-05-02 |
ID Biomedical Corporation of Quebec |
Vaccine
|
|
CA2768186A1
(en)
*
|
2009-07-15 |
2011-01-20 |
Novartis Ag |
Rsv f protein compositions and methods for making same
|
|
US9405700B2
(en)
|
2010-11-04 |
2016-08-02 |
Sonics, Inc. |
Methods and apparatus for virtualization in an integrated circuit
|
|
US9585953B2
(en)
|
2011-03-22 |
2017-03-07 |
Mucosis B.V. |
Immunogenic compositions in particulate form and methods for producing the same
|
|
CA2835644C
(en)
|
2011-05-13 |
2021-06-15 |
Novartis Ag |
Pre-fusion rsv f antigens
|
|
ES2395677B1
(es)
|
2011-07-29 |
2013-12-26 |
Instituto De Salud Carlos Iii |
Proteína F del VRSH en conformación pre-fusión estabilizada y anticuerpos neutralizantes específicos frente a la misma.
|
|
MX377591B
(es)
|
2014-10-15 |
2025-03-10 |
Amgen Inc |
Elementos promotores y reguladores para mejorar la expresión de genes heterólogos en células hospederas.
|
|
KR20260047644A
(ko)
|
2017-03-30 |
2026-04-08 |
더 유니버서티 어브 퀸슬랜드 |
키메라 분자 및 그의 용도
|